{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "As shown in XREF_TABLE, and similar to findings in nondiabetic subjects, reduction in \" hard \" CVD outcomes (CHD death and nonfatal MI) can be more clearly seen in diabetic subjects with high baseline CVD risk (known CVD and/or very high LDL cholesterol levels), but overall the benefits of statin therapy in people with diabetes at moderate or high risk for CVD are convincing.",
  "reading_complete" : "2020-07-28T16:42:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:28:00Z",
  "trigger" : "levels",
  "evidence" : [ "cholesterol levels" ],
  "pmc_id" : "2797382",
  "score" : 0
}